-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Since the second half of 2021, the senior management of listed companies in the pharmaceutical industry has continued to change frequently, involving positions including chairman, vice president, and deputy general manager.
According to incomplete statistics from the author, there is only the chairman of the board, and there have been at least 8 The chairman of a pharmaceutical company resigned
.
Northeast Pharmaceutical On September 29, Northeast Pharmaceutical announced that the company received a written resignation report from Mr.
Guo Qiyong on September 28, 2021
.
Due to job changes, Mr.
Guo Qiyong applied for resignation as the chairman of the company
.
The announcement shows that after Mr.
Guo Qiyong resigned, he still served as a director of the company's eighth board of directors, chairman of the strategy committee, and a member of the nomination committee
.
As of the date of this announcement, Mr.
Guo Qiyong does not hold any company shares
.
Yuexin Health On September 28, Yuexin Health issued an announcement stating that the company’s board of directors had recently received an application from the company’s chairman and president, Mr.
Li Cixiong, to resign as the company’s president
.
Based on the company’s business management and long-term development strategy considerations, in order to focus more on overall thinking and control the company’s strategy and overall business, the chairman and president of the company, Mr.
Li Cixiong, applied to the company’s board of directors to resign as president of the company, and the application for resignation was delivered to the board of directors.
Effective on the date
.
Mr.
Li Cixiong will continue to serve as the chairman of the company after he resigned as president
.
Stellite On September 16, Stellite issued an announcement stating that the board of directors recently received a written notice from Chairman Hu Jinsheng that due to his age, he proposed to the board of directors to resign as chairman, and that he will continue to serve as a director and a member of the strategy committee of the board of directors.
.
At the same time, the announcement indicated that the board of directors agreed to elect Hu Jian as the new chairman and chairman of the strategy committee of the board of directors, and at the same time to remove his vice chairman from the board of directors' review and approval date to the expiry date of the current board of directors
.
On the evening of September 1st, Hanhui Pharmaceuticals issued an announcement.
Since September 1, Liu Qi will resign as chairman of Hanhui Pharmaceuticals and will be replaced by Chen Xiaohua; at the same time, Hu Zhiqiang will resign as CEO of Hanhui Pharmaceuticals.
Li Yue took over
.
The company's LT team will report directly to CEO Li Yue
.
Zhongxin Pharmaceutical Zhongxin Pharmaceutical announced on the evening of July 20 that the company's board of directors received Li Liqun's written resignation yesterday.
Li Liqun applied for resignation as director and chairman of the company due to job changes
.
After resigning the above positions, Li Liqun is still working in the company
.
Baike Biologicals On July 13, Baike Biologicals announced to the public that the board of directors had recently received an application for resignation from director An Jixiang
.
As he reached the legal retirement age, Mr.
An Jixiang applied to resign from his position as chairman, director, and convener of the fourth board of directors' strategic decision-making committee
.
Hengrui Pharmaceuticals Hengrui Pharmaceuticals announced on the evening of July 9 that Zhou Yunshu, the chairman and general manager of the company, has applied for the resignation of the company's chairman, general manager and special committees of the board due to physical reasons.
The resignation report will take effect from the date of delivery to the company's board of directors.
.
The announcement also showed that before the by-election of the new chairman, the company's board of directors unanimously elected director Sun Piaoyang to perform the duties of the chairman until the board of directors elected a new chairman
.
Yan'an Bikang On July 7, Yan'an Bikang issued an announcement stating that the board of directors had recently received written resignation reports from Chairman Gu Xiaojia, Vice Chairman Li Jingkun, Directors He Yudong, Deng Qing, Wang Dong, and Vice President Yue Hongbo
.
Due to personal reasons, the above-mentioned personnel applied for resignation from their positions
.
According to incomplete statistics from the author, there is only the chairman of the board, and there have been at least 8 The chairman of a pharmaceutical company resigned
.
Northeast Pharmaceutical On September 29, Northeast Pharmaceutical announced that the company received a written resignation report from Mr.
Guo Qiyong on September 28, 2021
.
Due to job changes, Mr.
Guo Qiyong applied for resignation as the chairman of the company
.
The announcement shows that after Mr.
Guo Qiyong resigned, he still served as a director of the company's eighth board of directors, chairman of the strategy committee, and a member of the nomination committee
.
As of the date of this announcement, Mr.
Guo Qiyong does not hold any company shares
.
Yuexin Health On September 28, Yuexin Health issued an announcement stating that the company’s board of directors had recently received an application from the company’s chairman and president, Mr.
Li Cixiong, to resign as the company’s president
.
Based on the company’s business management and long-term development strategy considerations, in order to focus more on overall thinking and control the company’s strategy and overall business, the chairman and president of the company, Mr.
Li Cixiong, applied to the company’s board of directors to resign as president of the company, and the application for resignation was delivered to the board of directors.
Effective on the date
.
Mr.
Li Cixiong will continue to serve as the chairman of the company after he resigned as president
.
Stellite On September 16, Stellite issued an announcement stating that the board of directors recently received a written notice from Chairman Hu Jinsheng that due to his age, he proposed to the board of directors to resign as chairman, and that he will continue to serve as a director and a member of the strategy committee of the board of directors.
.
At the same time, the announcement indicated that the board of directors agreed to elect Hu Jian as the new chairman and chairman of the strategy committee of the board of directors, and at the same time to remove his vice chairman from the board of directors' review and approval date to the expiry date of the current board of directors
.
On the evening of September 1st, Hanhui Pharmaceuticals issued an announcement.
Since September 1, Liu Qi will resign as chairman of Hanhui Pharmaceuticals and will be replaced by Chen Xiaohua; at the same time, Hu Zhiqiang will resign as CEO of Hanhui Pharmaceuticals.
Li Yue took over
.
The company's LT team will report directly to CEO Li Yue
.
Zhongxin Pharmaceutical Zhongxin Pharmaceutical announced on the evening of July 20 that the company's board of directors received Li Liqun's written resignation yesterday.
Li Liqun applied for resignation as director and chairman of the company due to job changes
.
After resigning the above positions, Li Liqun is still working in the company
.
Baike Biologicals On July 13, Baike Biologicals announced to the public that the board of directors had recently received an application for resignation from director An Jixiang
.
As he reached the legal retirement age, Mr.
An Jixiang applied to resign from his position as chairman, director, and convener of the fourth board of directors' strategic decision-making committee
.
Hengrui Pharmaceuticals Hengrui Pharmaceuticals announced on the evening of July 9 that Zhou Yunshu, the chairman and general manager of the company, has applied for the resignation of the company's chairman, general manager and special committees of the board due to physical reasons.
The resignation report will take effect from the date of delivery to the company's board of directors.
.
The announcement also showed that before the by-election of the new chairman, the company's board of directors unanimously elected director Sun Piaoyang to perform the duties of the chairman until the board of directors elected a new chairman
.
Yan'an Bikang On July 7, Yan'an Bikang issued an announcement stating that the board of directors had recently received written resignation reports from Chairman Gu Xiaojia, Vice Chairman Li Jingkun, Directors He Yudong, Deng Qing, Wang Dong, and Vice President Yue Hongbo
.
Due to personal reasons, the above-mentioned personnel applied for resignation from their positions
.